| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |